搜索结果

Search Results for " hemoglobinuria "

Targets Recommended: Complement System

抑制剂 & 化合物

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T9189	Iptacopan hydrochloride Iptacopan HCl,LNP023 hydrochloride	Complement System	Immunology/Inflammation
	Iptacopan hydrochloride (LNP023 hydrochloride) 是一种可口服、高效和高选择性的因子 B 抑制剂，IC50 为 10 nM。 LNP023 显示与人因子 B 的直接、可逆和高亲和力结合，KD 为 7.9 nM。
T76867	Ravulizumab ALXN1210	Complement System	Immunology/Inflammation
	Ravulizumab (ALXN1210) 是一种靶向补体因子 5 的人源化单克隆抗体，它以高亲和力特异性结合人补体蛋白 C5，可阻断补体激活。Ravulizumab 可用于预防和治疗阵发性睡眠性血红蛋白尿症、非典型溶血性尿毒症综合征和重症肌无力。
T8509	Danicopan ACH-4471	Complement System	Immunology/Inflammation
	Danicopan (ACH-4471) 是一种可口服的小分子 D 因子选择性抑制剂，对人 D 因子具有高结合亲和力，Kd 值为 0.54 nM。它可抑制补体替代途径 (APC) 的活性，具有阻断阵发性夜间血红蛋白尿 (PNH) 和非典型溶血性尿毒症综合征 (aHUS) 的补体替代途径的潜力。
T77190	Crovalimab
	Crovalimab (SKY59; RO7112689)是一种人源化抗C5抗体，其通过pH依赖性机制发挥作用，其KD值在pH 7.4时为15.2nM，在pH 5.8时为16.8μM。该化合物还以高亲和力结合于人FcRn(KD: 17μM; pH 6.0)。通过阻断C5转化酶对C5的切割及抑制C5变体(p.Arg885His)的活性，Crovalimab能够显著抑制补体系统中经典途径(CP)、凝集素途径(LP)以及旁路途径(AP)中C5b-9的形成。因此，Crovalimab展现出作为研究阵发性睡眠性血红蛋白尿(PNH)及其他补体介导疾病的潜力。
T64692	AMY-101 acetate
	Complement component C3 plays a particularly versatile role in this process by keeping the cascade alert, acting as a point of convergence of activation pathways, fueling the amplification of the complement response, exerting direct effector functions, and helping to coordinate downstream immune responses[3]. In C3-/- mice alcohol-induced liver steatosis is absent or strongly reduced after chronic or acute alcohol exposure. This suggests that the complement system and its component C3 contribute...

化合物

Iptacopan hydrochloride

Cat.No: T9189

Synonym: Iptacopan HCl,LNP023 hydrochloride

Target: Complement System

Ravulizumab

Cat.No: T76867

Synonym: ALXN1210

Target: Complement System

Danicopan

Cat.No: T8509

Synonym: ACH-4471

Target: Complement System

Species：

Expression System：

Tag：

Cat. No.	Product Name	Species	Expression System
TMPY-02266	CD59a Protein, Mouse, Recombinant (His) CD59a antigen,Cd59,protectin,RP24-297H17.1,AA987121	Mouse	HEK293
	Protectin, a complement regulatory protein, also known as CD59, or MIRL (membrane inhibitor of reactive lysis) is a small protein that inhibits the complement membrane attack complex by binding C5b678 and preventing C9 from binding and polymerizing. The amino-terminal 25 amino acids represented a typical signal peptide sequence and the carboxy-terminal hydrophobic amino acids were characteristic for phosphatidylinositol-anchored proteins. It was found that the CD59/Protectin antigen is a small p...
TMPY-02503	CD59a Protein, Mouse, Recombinant (hFc) AA987121,CD59a antigen,Cd59,protectin,RP24-297H17.1	Mouse	HEK293
	Protectin, a complement regulatory protein, also known as CD59, or MIRL (membrane inhibitor of reactive lysis) is a small protein that inhibits the complement membrane attack complex by binding C5b678 and preventing C9 from binding and polymerizing. The amino-terminal 25 amino acids represented a typical signal peptide sequence and the carboxy-terminal hydrophobic amino acids were characteristic for phosphatidylinositol-anchored proteins. It was found that the CD59/Protectin antigen is a small p...

重组蛋白

CD59a Protein, Mouse, Recombinant (His)

Cat.No: TMPY-02266

Species: Mouse

Expression System: HEK293

CD59a Protein, Mouse, Recombinant (hFc)

Cat.No: TMPY-02503

Species: Mouse

Expression System: HEK293

* 搜索：		* 机关/企业：
* 邮箱：		* 电话：
备注：
验证码：

搜索结果

抑制剂 & 化合物

重组蛋白

提交您的定制咨询

化合物

重组蛋白